The Duration of Humoral Immunity and the Memory Cell Function After Vaccination With 7-Valent Pneumococcal Conjugate Vaccine in CLL (KLL2).
Phase of Trial: Phase IV
Latest Information Update: 18 Feb 2014
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms KLL2
- 29 Mar 2012 Planned end date changed from 1 Dec 2011 to 1 Dec 2012 as reported by ClinicalTrials.gov.
- 23 Jun 2009 New trial record